Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PF-3845 has antiallodynic effects in preclinical study

Aug. 6, 2010

TM-38837 shows favorable safety and pharmacokinetics in healthy subjects

Aug. 5, 2010

Japanese scientists identify potential biomarkers for coronary artery disease

Aug. 5, 2010

Candesartan inhibits fibrosis in rat model of RMI by suppressing sFRP-2

Aug. 5, 2010

TBR-652 exhibits potent anti-HIV activity in phase II trial

Aug. 4, 2010

Reduced TSPO expression and low progesterone are linked to MDD

Aug. 3, 2010

Promising preliminary phase II data disclosed on HIV immunotherapeutic AGS-004

Aug. 3, 2010

Suven Life Sciences presents new agents with encouraging in vivo procognitive activity

Aug. 3, 2010

Astaxanthin derivatives show promise in preclinical models of cardiovascular inflammation

Aug. 2, 2010

Sexual dysfunction in schizophrenia linked to typical antipsychotics, prolactin and DRD2 genotype

Aug. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...